The activity-integrated method for quality assessment of reduning injection by on-line DPPH-CE-DAD
A sensitive on-line DPPH-CE-DAD method was developed and validated for both screening and determining the concentration of seven antioxidants of Reduning injection. The pH and concentrations of buffer solution, SDS, β-CD and organic modifier were studied for the detection of DPPH and seven antioxida...
Saved in:
Published in: | PloS one Vol. 9; no. 9; p. e106254 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Public Library of Science
02-09-2014
Public Library of Science (PLoS) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A sensitive on-line DPPH-CE-DAD method was developed and validated for both screening and determining the concentration of seven antioxidants of Reduning injection. The pH and concentrations of buffer solution, SDS, β-CD and organic modifier were studied for the detection of DPPH and seven antioxidants. By on-line mixing DPPH and sample solution, a DPPH-CE method for testing the antioxidant activity of the complex matrix was successfully established and used to screen the antioxidant components of Reduning injection. Then, antioxidant components including caffeic acid, isochlorogenic acid A, isochlorogenic acid B, isochlorogenic acid C, chlorogenic acid, neochlorogenic acid and cryptochlorogenic acid were quantified by the newly established CE-DAD method. Finally, the total antioxidant activity and the multiple active components were selected as markers to evaluate the quality of Reduning injection. The results demonstrated that the on-line DPPH-CE-DAD method was reagent-saving, rapid and feasible for on-line simultaneous determination of total pharmacological activity and contents of multi-components samples. It was also a powerful method for evaluating the quality control and mechanism of action of TCM injection. |
---|---|
Bibliography: | Competing Interests: There are no competing interests and financial disclosure that declare the affiliation(s) to Kanion Pharmaceutical Co., LTD, along with any other relevant declarations relating to employment, consultancy, patents, products in development or marketed products etc. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: YC. Performed the experiments: J. Liu J. Li EL JH YB. Analyzed the data: YC J. Liu. Contributed reagents/materials/analysis tools: XJ XG BZ WX ZW. Wrote the paper: YC J. Liu. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0106254 |